Issue 122 • September 2022 No drugs for prions: new approaches to quell therapeutic scarcity Can generics producers tackle complex and specialty drugs? Omicron boosters will reinvigorate injectables manufacturing In association with NICE makeover: a new look for the UK's HTAs UK’s health technology assessments (HTAs) enter a new era following changes at NICE and a growing diversion from EU standards In association with Issue 122 Brought to you by 08/22/2022 11:00:33